• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,787
2,308
2,237
1,865
1,727

COUNTRY

1,033
871
272
254
210

CATEGORIES

  • 858
  • 186
  • 681
  • 1,129
  • 399
  • 270
  • 255
  • 66
  • 382
  • 728
  • 1,341
  • 1,356
  • 626
  • 884
  • 1,708
  • 2,691
  • 507
  • 734
  • 0
  • 93

PRICE

7,470
12,515
20,278
26,510

PUBLISHED

2,927
3,753
8,316
26,510

PRODUCT TYPE

21,635
2,901
872
827
164
44
21
21
18
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Sepsis Global Clinical Trials Review, H2, 2013

Sepsis Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Sepsis Global Clinical Trials Review, H2, 2013" provides data on the Sepsis clinical trial scenario This report provides...

September 2013
FROM

Hyponatremia Global Clinical Trials Review, H2, 2013

Hyponatremia Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Hyponatremia Global Clinical Trials Review, H2, 2013" provides data on the Hyponatremia clinical trial scenario....

September 2013
FROM

Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013

Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013"...

September 2013
FROM

Exelon (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Exelon (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Exelon (Alzheimer’s Disease) - Forecast and Market...

September 2013
FROM

Schistosomiasis Global Clinical Trials Review, H2, 2013

Schistosomiasis Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Schistosomiasis Global Clinical Trials Review, H2, 2013" provides data on the Schistosomiasis clinical trial...

September 2013
FROM

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Greece

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Greece Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory...

September 2013
FROM

Sickle Cell Disease Global Clinical Trials Review, H2, 2013

Sickle Cell Disease Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, H2, 2013" provides data on the Sickle Cell Disease...

September 2013
FROM

Aphasia Global Clinical Trials Review, H2, 2013

Aphasia Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Aphasia Global Clinical Trials Review, H2, 2013" provides data on the Aphasia clinical trial scenario. This report...

September 2013
FROM

Dengue Global Clinical Trials Review, H2, 2013

Dengue Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Dengue Global Clinical Trials Review, H2, 2013" provides data on the Dengue clinical trial scenario. This report...

September 2013
FROM
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: USA IMS Pharmaceutical Pricing & Reimbursement Concise Guide: USA - Product Thumbnail Image

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: USA

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise...

September 2013

Psoriatic Arthritis Global Clinical Trials Review, H2, 2013

Psoriatic Arthritis Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, H2, 2013" provides data on the Psoriatic Arthritis...

September 2013
FROM

Gastroenteritis Global Clinical Trials Review, H2, 2013

Gastroenteritis Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Gastroenteritis Global Clinical Trials Review, H2, 2013" provides data on the Gastroenteritis clinical trial...

September 2013
FROM

Partnerships, Licensing, Investments and M&A Deals and Trends for 08, 2013 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals Summary Our “Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals”...

September 2013
FROM

Hemoglobinuria Global Clinical Trials Review, H2, 2013

Hemoglobinuria Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Hemoglobinuria Global Clinical Trials Review, H2, 2013" provides data on the Hemoglobinuria clinical trial...

September 2013
FROM

Razadyne/Reminyl (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Razadyne/Reminyl (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Razadyne/Reminyl (Alzheimer’s Disease) -...

September 2013
FROM

Ulcerative Colitis Global Clinical Trials Review, H2, 2013

Ulcerative Colitis Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2013" provides data on the Ulcerative Colitis clinical...

September 2013
FROM

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid...

September 2013
FROM

Vital Signs - The Global Market for Type 2 Diabetes Therapeutics

This issue of Vital Signs, released on September 30, 2013, provides a market overview and drug pipeline analysis of Type 2 diabetes therapeutics Additionally, a company spotlight is provided for Trovagene...

September 2013
FROM

PharmaPoint: Meningococcal Vaccines - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - France Drug Forecast...

September 2013
FROM

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India Summary GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and...

September 2013
FROM
Loading Indicator

Our Clients

Our clients' logos